Success Stories: A Quality Control Analyst II in the Field of Vaccine Immunology Secures both NIW and EB1-A Approvals with our Firm’s Constant Help

Posted by wegreened on February 7, 2024 in EB1 Green Card, NIW, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonial:

“Great experience with Chen immigration attorneys and excellent quality of reference letters and petitions generated by them! They definitely made it easier for me in this stressful time to get everything streamlined and submitted in a very time-sensitive manner. I will 100% recommend them to anyone else who needs green card processing help! Thank you for all your hard work and excellent quality of work!”

On February 9^th, 2023, and July 24^th, 2023, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approval for a Quality Control Analyst II in the Field of Vaccine Immunology (Approval Notice).

General Field: Vaccine immunology

Position at the Time of Case Filing: Quality Control Analyst II

Country of Origin: India

State of Residence at the Time of Filing: Maryland

Approval Notice Date: February 9^th, 2023 (NIW) and July 24^th, 2023 (EB-1A)

Processing Time: 3 months, 2 days (NIW) and 4 months, 11 days (EB-1A)

Case Summary:

An EB-2 NIW (National Interest Waiver) petition approval was granted to a quality control analyst II with an MS in pharmaceutical sciences and drug delivery systems from India. Before moving ahead with a client-attorney agreement, our law group evaluated her provided credentials to determine her NIW’s success. We declared that we could lead her to obtain the national interest waiver after a complete evaluation only.

Our team thus followed a full-fledged process of analyzing her background, paperwork, and the associated evidence, and were then only confident that they were enough to persuade USCIS and get her the required approval.

Since the method of obtaining a green card involves two steps, that is, filing an I-140 petition and an I-485 application, our client even retained us for another I-140 petition under the EB-1A (Alien of Extraordinary Ability) visa category.

We noted the following important aspects to make her case a success:

The 3 peer-reviewed scientific articles she published in some of the most discerning, high-impact journals in her field of vaccine immunology.
An awe-inspiring record of obtaining 483 citations in other peer-reviewed journal articles.
Cited by researchers in at least 41 countries.
Also, she has conducted at least 5 reviews for at least 3 journals and conference proceedings.

Moreover, our client’s vaccine development and clinical trial quality control research addresses some of our nation’s and the world’s most pressing issues, including the need for safe and effective vaccines for various diseases, such as tuberculosis and HIV. Her strong background in the way vaccine regimens affect the immune system and the mechanisms regulating vaccine protection has allowed her research to be particularly original, resulting in her success in fundamentally transforming vaccine development approaches.

Furthermore, our client’s research has regularly received funding from the prestigious National Institutes of Health and the Bill and Melinda Gates Foundation. This funding supports projects that enhance health, reduce illness and disability, and minimize disease.

Therefore her impressive background, strong record of past achievements, recognition of expertise by journals seeking her services to review manuscripts, and unique knowledge relevant to her current and future work indicate not only that she qualifies as an alien of extraordinary ability but also that her entry will substantially benefit prospectively the United States.

Moreover, the following statement is excerpted from one of the four recommendation letters submitted:

“For this reason and others that I will list in this letter, I urge you to allow [client’s] research within the United States to continue without delay. Not only does her work benefit national interests, but her research holds an incredibly valuable place in her academic field and the global scientific community as they pursue novel treatment measures for some of the most infectious and devastating conditions that exist today.”

This evidence shows that our client is one of that small percentage who has risen to the very top of her field and has sustained both national and international acclaim. She is therefore fully qualified as an individual of extraordinary ability in her field of expertise.

We are exhilarated that our team was once again successful in persuading USCIS of the importance of our client’s research in the United States. Thus, she was granted not only NIW but also EB1-A approval with our firm’s consistent support. We would sincerely like to thank her for choosing our law firm for the I-140 petitions and wish her success in her future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%